Yacine Jaïdi
@yacinejaidi.bsky.social
Geriatrician | MD, PhD |
Father, runner, lurker, curious and simple human being
Opinions are my own
🇫🇷 🇹🇳 | 🇵🇸✊🏼
Father, runner, lurker, curious and simple human being
Opinions are my own
🇫🇷 🇹🇳 | 🇵🇸✊🏼
Reposted by Yacine Jaïdi
The interpretation of blood tests in terms of predictive values depends on the pre-test probability of being amyloid-positive, and therefore on the clinical context. So clinic first! See @suzanneeschindler.bsky.social paper for the global CEO initiative: www.nature.com/articles/s41...
Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease - Nature Reviews Neurology
Anti-amyloid treatments for early symptomatic Alzheimer disease have greatly increased the need for biomarker confirmation of amyloid pathology and blood biomarker tests offer an accessible and scalab...
www.nature.com
November 26, 2024 at 8:32 AM
The interpretation of blood tests in terms of predictive values depends on the pre-test probability of being amyloid-positive, and therefore on the clinical context. So clinic first! See @suzanneeschindler.bsky.social paper for the global CEO initiative: www.nature.com/articles/s41...